Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for CI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 207.00M
March 31, 2026 -1.141B
December 31, 2025 -4.066B
September 30, 2025 2.659B
June 30, 2025 -1.333B
March 31, 2025 -3.681B
December 31, 2024 -3.248B
September 30, 2024 439.00M
June 30, 2024 -2.309B
March 31, 2024 -2.529B
December 31, 2023 -1.25B
September 30, 2023 -2.572B
June 30, 2023 -435.00M
March 31, 2023 -37.00M
December 31, 2022 -2.636B
September 30, 2022 -5.517B
June 30, 2022 -916.00M
March 31, 2022 -2.171B
December 31, 2021 -2.371B
September 30, 2021 -1.728B
June 30, 2021 -62.00M
March 31, 2021 -4.051B
December 31, 2020 -4.721B
September 30, 2020 -1.682B
June 30, 2020 -312.00M
Date Value
March 31, 2020 -1.818B
December 31, 2019 -1.707B
September 30, 2019 -1.173B
June 30, 2019 -1.773B
March 31, 2019 -2.534B
December 31, 2018 4.40B
September 30, 2018 19.66B
June 30, 2018 -12.00M
March 31, 2018 -530.00M
December 31, 2017 -683.00M
September 30, 2017 -825.00M
June 30, 2017 -628.00M
March 31, 2017 -515.00M
December 31, 2016 30.00M
September 30, 2016 -32.00M
June 30, 2016 -77.00M
March 31, 2016 -146.00M
December 31, 2015 -105.00M
September 30, 2015 21.00M
June 30, 2015 -1.049B
March 31, 2015 603.00M
December 31, 2014 -358.00M
September 30, 2014 -217.00M
June 30, 2014 -508.00M
March 31, 2014 -499.00M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Centene Corp. -259.00M
CVS Health Corp. -2.693B
Humana, Inc. 249.00M
UnitedHealth Group, Inc. -8.623B
Elevance Health, Inc. -1.494B